Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women.
Saved in:
| Title: | Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women. |
|---|---|
| Authors: | Gupta N; Department of Radiation Oncology, Government Medical College and Hospital, Chandigarh, India., Gupta D; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Dixit J; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Mehra N; Department of Medical Oncology, Adyar Cancer Institute, Chennai, Tamil Nadu, India., Singh A; Department of Medical Oncology, Christian Medical College, Vellore, Tamil Nadu, India., Krishnamurthy MN; Department of Clinical Pharmacology, Tata Memorial Centre, Mumbai, Maharashtra, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Jyani G; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Rajsekhar K; Department of Health Research, Ministry of Health and Family Welfare, New Delhi, India., Kalaiyarasi JP; Department of Medical Oncology, Adyar Cancer Institute, Chennai, Tamil Nadu, India., Roy PS; Department of Medical Oncology, Dr. B. Booroah Cancer Institute, Guwahati, Assam, India., Malik PS; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India., Mathew A; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India., Malhotra P; Department of Internal Medicine, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India., Gupta S; Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India., Kumar L; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India., Kataki A; Department of Gynaecologic Oncology, Dr. B. Booroah Cancer Institute, Guwahati, Assam, India., Prinja S; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. shankarprinja@gmail.com. |
| Source: | Applied health economics and health policy [Appl Health Econ Health Policy] 2022 Jul; Vol. 20 (4), pp. 609-621. Date of Electronic Publication: 2022 May 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Open Mind Journals Ltd Country of Publication: New Zealand NLM ID: 101150314 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1896 (Electronic) Linking ISSN: 11755652 NLM ISO Abbreviation: Appl Health Econ Health Policy Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35534752 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gupta+N%22">Gupta N</searchLink>; Department of Radiation Oncology, Government Medical College and Hospital, Chandigarh, India.<br /><searchLink fieldCode="AU" term="%22Gupta+D%22">Gupta D</searchLink>; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.<br /><searchLink fieldCode="AU" term="%22Dixit+J%22">Dixit J</searchLink>; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.<br /><searchLink fieldCode="AU" term="%22Mehra+N%22">Mehra N</searchLink>; Department of Medical Oncology, Adyar Cancer Institute, Chennai, Tamil Nadu, India.<br /><searchLink fieldCode="AU" term="%22Singh+A%22">Singh A</searchLink>; Department of Medical Oncology, Christian Medical College, Vellore, Tamil Nadu, India.<br /><searchLink fieldCode="AU" term="%22Krishnamurthy+MN%22">Krishnamurthy MN</searchLink>; Department of Clinical Pharmacology, Tata Memorial Centre, Mumbai, Maharashtra, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Jyani+G%22">Jyani G</searchLink>; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.<br /><searchLink fieldCode="AU" term="%22Rajsekhar+K%22">Rajsekhar K</searchLink>; Department of Health Research, Ministry of Health and Family Welfare, New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Kalaiyarasi+JP%22">Kalaiyarasi JP</searchLink>; Department of Medical Oncology, Adyar Cancer Institute, Chennai, Tamil Nadu, India.<br /><searchLink fieldCode="AU" term="%22Roy+PS%22">Roy PS</searchLink>; Department of Medical Oncology, Dr. B. Booroah Cancer Institute, Guwahati, Assam, India.<br /><searchLink fieldCode="AU" term="%22Malik+PS%22">Malik PS</searchLink>; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Mathew+A%22">Mathew A</searchLink>; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Malhotra+P%22">Malhotra P</searchLink>; Department of Internal Medicine, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.<br /><searchLink fieldCode="AU" term="%22Gupta+S%22">Gupta S</searchLink>; Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India.; Homi Bhabha National Institute, Mumbai, Maharashtra, India.<br /><searchLink fieldCode="AU" term="%22Kumar+L%22">Kumar L</searchLink>; Department of Medical Oncology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.<br /><searchLink fieldCode="AU" term="%22Kataki+A%22">Kataki A</searchLink>; Department of Gynaecologic Oncology, Dr. B. Booroah Cancer Institute, Guwahati, Assam, India.<br /><searchLink fieldCode="AU" term="%22Prinja+S%22">Prinja S</searchLink>; Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. shankarprinja@gmail.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101150314%22">Applied health economics and health policy</searchLink> [Appl Health Econ Health Policy] 2022 Jul; Vol. 20 (4), pp. 609-621. <i>Date of Electronic Publication: </i>2022 May 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Open+Mind+Journals+Ltd%22">Open Mind Journals Ltd </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101150314 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1896 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211755652%22">11755652 </searchLink><i>NLM ISO Abbreviation: </i>Appl Health Econ Health Policy <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35534752 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40258-022-00731-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 609 Titles: – TitleFull: Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian Women. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gupta N – PersonEntity: Name: NameFull: Gupta D – PersonEntity: Name: NameFull: Dixit J – PersonEntity: Name: NameFull: Mehra N – PersonEntity: Name: NameFull: Singh A – PersonEntity: Name: NameFull: Krishnamurthy MN – PersonEntity: Name: NameFull: Jyani G – PersonEntity: Name: NameFull: Rajsekhar K – PersonEntity: Name: NameFull: Kalaiyarasi JP – PersonEntity: Name: NameFull: Roy PS – PersonEntity: Name: NameFull: Malik PS – PersonEntity: Name: NameFull: Mathew A – PersonEntity: Name: NameFull: Malhotra P – PersonEntity: Name: NameFull: Gupta S – PersonEntity: Name: NameFull: Kumar L – PersonEntity: Name: NameFull: Kataki A – PersonEntity: Name: NameFull: Prinja S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2022 Jul Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1179-1896 Numbering: – Type: volume Value: 20 – Type: issue Value: 4 Titles: – TitleFull: Applied health economics and health policy Type: main |
| ResultId | 1 |
